Effects of anesthetic drugs on 6-keto PG F1 alfa during thoracotomy

Effects of anesthetic drugs on 6-keto PG F1 alfa during thoracotomy - TPGF1a

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028856

Enrollment

Registered

2017-08-28

Start date

2017-08-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Flurbiprofen+remifentail Remifentanil Fentanyl

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients scheduled for lung resection under differential lung ventilation

Exclusion criteria

Exclusion criteria: Allergic history for flurbiprofen Kidney disease

Design outcomes

Primary

Measure	Time frame
6-keto prostaglandin F1 alfa	—

Secondary

Measure	Time frame
Blood pressure, heart rate, transcutaneous arterial saturation	—

Countries

Japan

Contacts

Public ContactHIromi Katoh

Hyogo Cancer Center Department of anestheisology

whoami@hp.pref.hyogo.jp078-929-1151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026